ATE311196T1 - Zusammensetzungen geeignet zur kontrollierten freisetzung des hormons gnrh und dessen analoga - Google Patents

Zusammensetzungen geeignet zur kontrollierten freisetzung des hormons gnrh und dessen analoga

Info

Publication number
ATE311196T1
ATE311196T1 AT98923763T AT98923763T ATE311196T1 AT E311196 T1 ATE311196 T1 AT E311196T1 AT 98923763 T AT98923763 T AT 98923763T AT 98923763 T AT98923763 T AT 98923763T AT E311196 T1 ATE311196 T1 AT E311196T1
Authority
AT
Austria
Prior art keywords
controlled release
analogues
gnrh
compositions suitable
hormone gnrh
Prior art date
Application number
AT98923763T
Other languages
English (en)
Inventor
Patrick J Burns
John W Gibson
Arthur J Tipton
Original Assignee
Durect Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26668592&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE311196(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Durect Corp filed Critical Durect Corp
Application granted granted Critical
Publication of ATE311196T1 publication Critical patent/ATE311196T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
AT98923763T 1997-05-28 1998-05-26 Zusammensetzungen geeignet zur kontrollierten freisetzung des hormons gnrh und dessen analoga ATE311196T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4778997P 1997-05-28 1997-05-28
US09/001,123 US6051558A (en) 1997-05-28 1997-12-30 Compositions suitable for controlled release of the hormone GnRH and its analogs
PCT/US1998/010668 WO1998053837A1 (en) 1997-05-28 1998-05-26 COMPOSITIONS SUITABLE FOR CONTROLLED RELEASE OF THE HORMONE GnRH AND ITS ANALOGS

Publications (1)

Publication Number Publication Date
ATE311196T1 true ATE311196T1 (de) 2005-12-15

Family

ID=26668592

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98923763T ATE311196T1 (de) 1997-05-28 1998-05-26 Zusammensetzungen geeignet zur kontrollierten freisetzung des hormons gnrh und dessen analoga

Country Status (10)

Country Link
US (1) US6051558A (de)
EP (1) EP1017411B1 (de)
AT (1) ATE311196T1 (de)
AU (1) AU743086C (de)
BR (1) BR9809189A (de)
CA (1) CA2291087C (de)
DE (1) DE69832631T2 (de)
ES (1) ES2255162T3 (de)
NZ (1) NZ501219A (de)
WO (1) WO1998053837A1 (de)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7833543B2 (en) * 1995-06-07 2010-11-16 Durect Corporation High viscosity liquid controlled delivery system and medical or surgical device
US6413536B1 (en) 1995-06-07 2002-07-02 Southern Biosystems, Inc. High viscosity liquid controlled delivery system and medical or surgical device
US20060025328A1 (en) * 1997-05-28 2006-02-02 Burns Patrick J Compositions suitable for controlled release of the hormone GnRH and its analogs
US6028057A (en) * 1998-02-19 2000-02-22 Thorn Bioscience, Llc Regulation of estrus and ovulation in gilts
AU5025300A (en) * 1999-06-18 2001-01-09 Southern Biosystems, Inc. Compositions for controlled release of the hormone gnrh and its analogs
US7074803B2 (en) * 2001-03-02 2006-07-11 Durect Corporation Opioid formulations
CA2406790C (en) * 2000-04-19 2009-07-07 Genentech, Inc. Sustained release formulations
AU2001296770A1 (en) * 2000-10-06 2002-04-15 Durect Corporation Devices and methods for management of inflammation
JP2004512369A (ja) * 2000-10-30 2004-04-22 ユニバーシティ・オブ・チューリッヒ 尿失禁の治療のためのｇｎｒｈアナログ
US20020151876A1 (en) * 2001-02-07 2002-10-17 Tai-Wah Chan Devices and methods for management of bone density
ES2554106T3 (es) * 2001-06-21 2015-12-16 Genentech, Inc. Formulación de liberación sostenida
WO2003080629A2 (en) 2002-02-25 2003-10-02 Guilford Pharmaceuticals, Inc. Phosphorus-containing compounds with polymeric chains, and methods of making and using the same
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
ATE482695T1 (de) * 2002-12-13 2010-10-15 Durect Corp Orale darreichungsform mit flüssigen hochviskosen trägersystemen
DK1684782T3 (en) * 2003-10-03 2015-11-02 Thorn Bioscience Llc PROCEDURE FOR SYNCHRONIZING OVULATION FOR TEMPORARY REGULATED BREEDING WITHOUT BROWN DETECTION
JP2007517042A (ja) * 2003-12-30 2007-06-28 デュレクト コーポレーション 活性物質、好ましくはｇｎｒｈの制御放出のための、好ましくはｐｅｇおよびｐｌｇの混合物を含有するポリマーインプラント
LT2767292T (lt) * 2004-09-17 2016-12-12 Durect Corporation Palaikomosios vietinės anestezijos mišinys su saib
WO2006071208A1 (en) * 2004-12-23 2006-07-06 Durect Corporation Polymeric implants, preferably containing a mixture of peg and plg, for controlled release of a gnrh
US20070027105A1 (en) 2005-07-26 2007-02-01 Alza Corporation Peroxide removal from drug delivery vehicle
US20080286375A1 (en) * 2005-11-15 2008-11-20 Amorepacific Corporation Method for Preparing Sustained-Release Microparticles Comprising Sucrose Acetate Isobutyrate
NZ595633A (en) * 2005-12-02 2013-05-31 Parnell Lab Aust Pty Ltd Increasing pregnancy rates
US20070197435A1 (en) * 2006-02-17 2007-08-23 Webel Stephen K Process for the synchronization of ovulation for timed breeding without heat detection
KR100908517B1 (ko) * 2006-07-04 2009-07-20 (주)아모레퍼시픽 호흡기계 약제 전달을 위한 서방형 다공성 미세입자 및 그제조 방법
DK2117521T3 (da) 2006-11-03 2012-09-03 Durect Corp Transdermale indgivelsessystemer omfattende bupivacain
AU2007234612B2 (en) 2006-12-14 2013-06-27 Johnson & Johnson Regenerative Therapeutics, Llc Protein stabilization formulations
US7678764B2 (en) 2007-06-29 2010-03-16 Johnson & Johnson Regenerative Therapeutics, Llc Protein formulations for use at elevated temperatures
EP2187932B1 (de) 2007-08-07 2015-01-28 DePuy Synthes Products, LLC Proteinformulierungen mit gdf-5 in wässriger saurer lösung
AU2008335809A1 (en) * 2007-12-06 2009-06-18 Durect Corporation Methods useful for the treatment of pain, arthritic conditions, or inflammation associated with a chronic condition
US20090181068A1 (en) * 2008-01-14 2009-07-16 Dunn Richard L Low Viscosity Liquid Polymeric Delivery System
WO2009100216A1 (en) 2008-02-08 2009-08-13 Qps Llc Composition for sustained release delivery of proteins or peptides
CA2714514C (en) 2008-02-08 2016-08-16 Qps Llc Non-polymeric compositions for controlled drug delivery
CN102026619A (zh) * 2008-04-14 2011-04-20 先进科技及再生医学有限责任公司 液体缓冲的gdf-5制剂
EP2307040B1 (de) 2008-05-29 2015-09-09 Isr Immune System Regulation Ab Gnrh und sexhormone zur behandlung von viruserkrankungen, insbesondere hiv/aids
US20100260844A1 (en) 2008-11-03 2010-10-14 Scicinski Jan J Oral pharmaceutical dosage forms
ES2661240T3 (es) 2009-04-23 2018-03-28 Jbs United Animal Health Ii Llc Método y composición para sincronizar el momento de inseminación
AR082266A1 (es) 2011-05-13 2012-11-28 Univ Nac Del Litoral Microparticula inyectable de liberacion controlada
ES2808409T3 (es) 2012-11-28 2021-02-26 United Ah Ii Llc Método para sincronizar el tiempo de inseminación en cerdas primerizas
TW201521769A (zh) 2013-03-15 2015-06-16 Durect Corp 具有流變改質劑以減少溶解變異性之組成物
WO2015158823A1 (de) 2014-04-16 2015-10-22 Veyx-Pharma Gmbh Veterinärpharmazeutische zusammensetzung und deren verwendung
US20170106017A1 (en) * 2014-05-16 2017-04-20 Neuraltus Pharmaceuticals, Inc. Methods and compositions for treatment of macrophage-related disorders
CL2016000217A1 (es) * 2016-01-27 2016-07-01 Farmacologia En Aquacultura Veterinaria Fav S A Nueva composición veterinaria inyectable para la sincronización del desove en peces
CN111202837B (zh) * 2018-11-22 2022-02-08 中国农业大学 一种用于控制马属动物排卵的制剂及控制排卵的方法
BR112022013784A2 (pt) 2020-01-13 2022-10-11 Durect Corp Sistemas de distribuição de fármacos de liberação prolongada com impurezas reduzidas e métodos relacionados
CN113350275B (zh) * 2021-06-19 2022-09-06 江西农业大学 一种烯丙孕素缓释注射液及其制备方法和应用
WO2023027950A1 (en) 2021-08-25 2023-03-02 Reprologix Methods for reproductive management of sheep and goats

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4411890A (en) * 1981-04-14 1983-10-25 Beckman Instruments, Inc. Synthetic peptides having pituitary growth hormone releasing activity
NO139560C (no) * 1972-04-29 1979-04-04 Takeda Chemical Industries Ltd Analogifremgangsmaate til fremstilling av terapeutisk virksomme nonapeptidamid-derivater
JPS5088069A (de) * 1973-11-01 1975-07-15
DE2438350C3 (de) * 1974-08-09 1979-06-13 Hoechst Ag, 6000 Frankfurt Peptide mit starker LH-RH/FSH-RH-Wirkung, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
GB1524747A (en) * 1976-05-11 1978-09-13 Ici Ltd Polypeptide
US5391381A (en) * 1987-06-25 1995-02-21 Alza Corporation Dispenser capable of delivering plurality of drug units
US5350741A (en) * 1988-07-30 1994-09-27 Kanji Takada Enteric formulations of physiologically active peptides and proteins
ATE164080T1 (de) * 1990-05-10 1998-04-15 Bechgaard Int Res Pharmazeutische zubereitung enthaltend n- glykofurole und n-äthylenglykole
IT1240643B (it) * 1990-05-11 1993-12-17 Mediolanum Farmaceutici Spa Peptidi biologicamente attivi contenenti in catena 2-alchiltriptofano
ZA918168B (en) * 1990-10-16 1993-04-14 Takeda Chemical Industries Ltd Prolonged release preparation and polymers thereof.
US5399363A (en) * 1991-01-25 1995-03-21 Eastman Kodak Company Surface modified anticancer nanoparticles
US5487898A (en) * 1991-08-26 1996-01-30 Abbott Laboratories Compositions and method for the sublingual or buccal administration therapeutic agents
YU87892A (sh) * 1991-10-01 1995-12-04 Eli Lilly And Company Lilly Corporate Center Injektibilne formulacije produženog otpuštanja i postupci za njihovo dobijanje i primenu
WO1993007833A1 (en) * 1991-10-21 1993-04-29 Peptide Technology Limited Biocompatible implant for the timing of ovulation in mares
TW282403B (de) * 1993-08-26 1996-08-01 Takeda Pharm Industry Co Ltd
CA2222567C (en) * 1995-06-07 2002-01-29 Southern Biosystems, Inc. High viscosity liquid controlled biologically active delivery system
US5747058A (en) * 1995-06-07 1998-05-05 Southern Biosystems, Inc. High viscosity liquid controlled delivery system
US5736152A (en) * 1995-10-27 1998-04-07 Atrix Laboratories, Inc. Non-polymeric sustained release delivery system
US5840329A (en) * 1997-05-15 1998-11-24 Bioadvances Llc Pulsatile drug delivery system

Also Published As

Publication number Publication date
ES2255162T3 (es) 2006-06-16
AU743086C (en) 2004-07-15
DE69832631T2 (de) 2006-08-10
EP1017411A1 (de) 2000-07-12
US6051558A (en) 2000-04-18
AU743086B2 (en) 2002-01-17
CA2291087C (en) 2009-12-29
WO1998053837A1 (en) 1998-12-03
DE69832631D1 (de) 2006-01-05
BR9809189A (pt) 2002-12-03
EP1017411B1 (de) 2005-11-30
AU7598098A (en) 1998-12-30
EP1017411A4 (de) 2002-09-04
NZ501219A (en) 2002-03-01
CA2291087A1 (en) 1998-12-03

Similar Documents

Publication Publication Date Title
ATE311196T1 (de) Zusammensetzungen geeignet zur kontrollierten freisetzung des hormons gnrh und dessen analoga
HK1015255A1 (en) High viscosity liquid controlled derlivery system
DK1274459T3 (da) Præparater med vedholdende frigivelse indeholdende væksthormon
IL112112A (en) Peptides with growth hormone releasing properties and pharmaceutical compositions containing them
MX9703550A (es) Secretagogos de hormona del crecimiento, peptidomimeticos, de bajo peso molecular.
HU900108D0 (en) Composition of controlled active ingredient delivery, operating by hydrogel
ZA961255B (en) Pharmaceutical composition containing nucleic acids and uses thereof
NZ311208A (en) Composition comprising an active agent dissolved in a glass-forming carrier comprising a glass-forming substance containing a plasticizer, composition is liquid or jelly-like below 50 degrees
GEP20022709B (en) Pharmaceutical Compositions Having Appetite Suppressant Activity
UA27143C2 (uk) Рідка фармацевтичhа композиція в формі аерозолю
BR9812313A (pt) Sistema de liberação controlada de lìquido de viscosidade elevada como um dispositivo
OA09772A (en) "mometasone furoate monohydrate, process for making same and pharmaceutical compositions".
ATE76588T1 (de) Zinkhaltige keramik.
JO2034B1 (en) Isotopes of the hormone peptide its uses and the chemical compounds it contains
ATE102022T1 (de) Zusammensetzung zur kontrollierten abgabe von medikamenten.
MY101919A (en) Pharmaceutical compositions
ZA884811B (en) Composition and use
ES2105501T3 (es) Unidades de dosificacion farmaceuticas revestidas de azucar.
IL91047A0 (en) Pharmaceutical compositions containing a zinc complex
MX9300586A (es) Nuevos fragmentos de hormona paratiroidea proceso para su preparacion y composiciones farmaceuticas que los contienen.
ATE546461T1 (de) Gnrh analog von nicht-säugertieren und verwendung zur regulierung der fruchtbarkeit und der schwangerschaft
SE9403389D0 (sv) Pharmaceutical composition containing derivattves of sex hormones
BG105303A (en) Pharmaceutical compositions comprising ibuprofen and domperidone
ZA87332B (en) Compositions containing fixed combinations
MX9802105A (es) Composiciones estabilizadas suavizadoras de telas.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties